作者的详细信息

Орлова, Рашида Вахидовна

期 栏目 标题 文件
卷 17, 编号 4 (2015) Articles Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas
卷 20, 编号 1 (2018) Articles Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series PDF
(Rus)
卷 24, 编号 1 (2022) CLINICAL ONCOLOGY Clinical and morphological features of breast tumors with PIK3CA mutations in Russian patients: Observational study PDF
(Rus) PDF
(Eng)
卷 24, 编号 4 (2022) CLINICAL ONCOLOGY Place of durvalumab in the treatment of biliary tract cancer: A review PDF
(Rus)
卷 25, 编号 3 (2023) CLINICAL ONCOLOGY Resolution of the advisory board on the topic: “The place of entrectinib in the treatment of adult patients with NTRK-fusion positive solid tumors” PDF
(Rus)
卷 24, 编号 4 (2022) CLINICAL ONCOLOGY Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study PDF
(Rus)
卷 25, 编号 3 (2023) CLINICAL ONCOLOGY Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study PDF
(Rus)
卷 26, 编号 1 (2024) Articles Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia PDF
(Rus)

##common.cookie##